• 13 May 22

Graft Polymer’s HACCP cert set to trigger sales and production capacity

Graft Polymer’s HACCP cert set to trigger sales and production capacity

Solvonis Therapeutics Plc | SVNS | 0.1 0.00 (0.0%)

    • 80 views

 

Graft Polymer’s Ekaterina Kulevskaia joined Katie to talk through the company’s approval of a hazard analysis and critical control point (HACCP) certificate to its research and development facility in Slovenia.

The award enables the company to enter the Business-to-Consumer market, adding a further revenue stream to the business.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Solvonis CEO says Awakn shareholder approval of acquisition is a 'great endorsement'

Companies: Solvonis Therapeutics Plc

Solvonis Therapeutics says FDA supports Phase 2b for AWKN-002 candidate

Companies: Solvonis Therapeutics Plc

Solvonis Therapeutics, Great Southern Copper, Ecora Resources, Helium One, CleanTech Lithium - Small Cap Snapshot

Companies: Solvonis Therapeutics Plc

Solvonis Therapeutics chairman on the future of biotech & neuroscience M&A

Companies: Solvonis Therapeutics Plc

Solvonis Therapeutics eyes completion of Awakn acquisition following transformative 2024

Companies: Solvonis Therapeutics Plc

Graft Polymer eager to push on after signing fresh manufacturing agreement

Companies: Solvonis Therapeutics Plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top